#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fusarium infection Mastocytosis Chronic hepatitis B Barth syndrome Diffuse large B-cell lymphoma recurrent Lymphoma Mantle cell lymphoma Heart disease congenital Uterine leiomyosarcoma Pulmonary tuberculosis Deafness bilateral Gastrointestinal stromal tumour VEXAS syndrome Anal fistula Thrombotic microangiopathy More trials…

    Learn about Rare Diseases

    Rhabdomyosarcoma Propionic acidaemia Isodicentric chromosome 15 syndrome – Treatment Breast angiosarcoma – Trials in Disease Usher’s syndrome – Treatment Haemolytic uraemic syndrome – Basic Information Richter’s syndrome – Treatment Hyperoxaluria Mantle cell lymphoma stage II – Treatment Atypical teratoid/rhabdoid tumour of CNS – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Abc-23B-116 Mometasone Furoate Monohydrate Ifinatamab Deruxtecan Setrusumab Festuca Elatior Pollen Extract Prasugrel Hydrobromide Sodium Tinzaparin Pf-06835375 Elraglusib Olorofim Ursodeoxycholic Acid Bevacizumab Maralixibat Chloride LY4170156 Cetuximab Danicopan Calcium Folinate Pentahydrate Iopromide Tecovirimat More therapies…

    Learn about Your Condition

    Cervix carcinoma stage II Hypertrophic scar Dyspnoea Osteoporosis Pterygium Cardiac failure chronic Pathogen resistance B-cell lymphoma Knee arthroplasty Plasma cell myeloma refractory Richter's syndrome Fibrous dysplasia of bone Tumour of ampulla of Vater Arteriosclerosis T-cell lymphoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Krajska nemocnice Liberec a.s.

Krajska nemocnice Liberec a.s.

Husová 357/10, Liberec, 460 63, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • A Study of Camizestrant Compared to Standard Hormone Therapy for Patients with ER-Positive HER2-Negative Early Breast Cancer After Initial Treatment

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Goserelin
    • Triptorelin
    • Tamoxifen Citrate
    Austria Belgium Bulgaria Croatia Czechia Estonia +10

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!